MENU
DYN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Dyne Therapeutics (DYN) Ownership - Who owns Dyne Therapeutics?

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more

Profile

Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
258
Web
https://www.dyne-tx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.05B
P/E Ratio
N/A
Total Cash
898.48M
Projected Growth
N/A
Total Debt
219.2M
Revenue
N/A
Risk (Beta)
2.33
Dividend Yield
N/A
Total Cash/Share
4.81
Total Debt/Equity
92.44
Revenue/Share
null USD as % of share price